Strokes in young adults: Epidemiology and prevention

Vascular Health and Risk Management

Volumn 11, Issue , 2015, Pages 157-164

  Smajlović, Dževdet ^a  

^a UNIVERSITY OF TUZLA   (Bosnia and Herzegovina)

Author keywords

Age; Cerebrovascular diseases; Etiology; Incidence; Management; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INCIDENCE; LIFESTYLE MODIFICATION; MORTALITY; PREVALENCE; PRIMARY PREVENTION; SECONDARY PREVENTION; SMOKING; SMOKING CESSATION; TRANSIENT ISCHEMIC ATTACK; YOUNG ADULT; AGE; MIDDLE AGED; PROCEDURES; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STROKE; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGE FACTORS; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; PRIMARY PREVENTION; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SECONDARY PREVENTION; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84924603197     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S53203     Document Type: Article

References (67)

1. Kissela BM, Khoury JC, Alwell K, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology. 2012;79: 1781–1787.
2. Nedeltchev K, der Maur TA, Georgiadis D, et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry. 2005;76:191–195.
3. Varona J F, Guerra JM, Bermejo F, Molina JA, Gomez de la Camara. Causes of ischemic stroke in young adults, and evolution of the etiological diagnosis over the long term. Eur Neurol. 2007;57: 212–218.
4. George MG, Tong X, Kuklina E V, Labarthe DR. Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995–2008. Ann Neurol. 2011;70:713–721.
5. Marini C, Russo T, Felzani G. Incidence of stroke in young adults: a review. Stroke Res Treat. 2011;2011:535672.
6. Smajlović DŽ, Salihović D, Ibrahimagić OĆ, Sinanović O. Characteristics of stroke in young adults in Tuzla Canton, Bosnia and Herzegovina. Coll Antropol. 2013;37:515–519.
7. Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15 to 49 with frst-ever ischemic stroke: the Helsinki Young Stroke Registry. Stroke. 2009;40:1195–1203.
8. Groppo E, De Gennaro R, Granieri G, et al. Incidence and prognosis of stroke in young adults: a population-based study in Ferrara, Italy. Neurol Sci. 2012;33:53–58.
9. Jacobs BS, Boden-Albala B, Lin IF, Sacco RL. Stroke in the young in the Northern Manhattan Stroke Study. Stroke, 2002;33: 2789–2793.
10. Barnett Pathak E, Sloan MA. Recent racial/ethnic disparities in stroke hospitalization and outcomes for young adults in Florida, 2001–2006. Neuroepidemiolog y. 2009;32:302–311.
11. Morikawa Y, Nakagawa H, Naruse Y, et al. Trends in stroke incidence and acute case fatality in a Japanese rural area: the Oyabe study. Stroke. 2000;31:1583–1587.
12. Kissela B, Schneider A, Kleindorfer D, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2 004;35: 426–431.
13. Lauria G, Gentile M, Fassetta G, et al. Incidence and prognosis of stroke in the Belluno Province, Italy: frst-year results of a community-based study. Stroke. 1995;26:1787–1793.
14. Vibo R, Körv J, Roose M. The third stroke registry in Tartu, Estonia: decline of stroke incidence and 28-day case fatality rate since 1991. Stroke. 2005;36:2544–2548.
15. Rasura M, Spalloni A, Ferrari M, et al. A case series of young stroke in Rome. Eur J Neurol. 2006;13:146–152.
16. Putaala J, Yesilot N, Waje-Andreassen U, et al. Demographic and geographic vascular risk factor differences in European young adults with ischemic stroke: the 1 5 Cities Young Stroke Study. Stroke. 2 012;43: 2624–2630.
17. Putaala J, Haapaniemi E, Kaste M, Tatlisumak T. How does number of risk factors affect prognosis in young patients with ischemic stroke? Stroke. 2012;43:356–361.
18. Zhang YN, He L. [Risk factors study of ischemic stroke in young adults in Southwest China]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012;43: 553–557. Chinese.
19. Wu TY, Kumar A, Wong EH. Young ischaemic stroke in South Auckland: a hospital-based study. N Z Med J. 2012;125:47–56.
20. Cerrato P, Grasso M, Imperiale D, et al. Stroke in young patients: etiopathogenesis and risk factors in different age classes. Cerebrovasc Dis. 2004;18:154–159.
21. Jovanovic DR, Beslac-Bumbasirevic L, Raicevic R, Zidverc-Trajkovic J, Ercegovac MD. Etiology of ischemic stroke among young adults of Serbia. Vojnosanit Pregl. 2008;65:803–809.
22. Spengos K, Vemmos K. Risk factors, etiology, and outcome of frst-ever ischemic stroke in young adults aged 15 to 45 – the Athens Young Stroke Registry. Eur J Neurol. 2010;17:1358–1364.
23. Tancredi L, Martinelli Boneschi F, Braga M, et al. Stroke care in young patients. Stroke Res Treat. 2013;2013:715380.
24. Yesilot Barlas N, Putaala J, Waje-Andreassen U, et al. Etiology of frst ever ischaemic stroke in European young adults: the 15 Cities Young Stroke Study. Eur J Neurol. 2013;20:1431–1439.
25. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classifcation of subtype of acute ischemic stroke. Defnitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.
26. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. New approach to stroke subtyping: the A-S-C-O (phenotypic) classifcation of stroke. Cerebrovasc Dis. 2009;27:502–508.
27. Mackey J. Evaluation and management of stroke in young adults. Continuum (Minneap Minn). 2014;20:352–369.
28. Bousser MG, Welch KM. Relation between migraine and stroke. Lancet Neurol. 2005;4:533–542.
29. Brey RL. Antiphospholipid antibodies in young adults with stroke. J Thromb Thrombolysis. 2005;20:105–112.
30. Birnbaum J, Hellmann DB. Primary angiitis of the central nervous system. Arch Neurol. 2009;66:704–709.
31. Onwuchekwa AC, Onwuchekwa RC, Asekomeh EG. Stroke in young Nigerian adults. J Vasc Nurs. 2009;27:98–102.
32. Hart RG. Cardiogenic embolism to the brain. Lancet. 1992;339: 589–594.
33. Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40: 2349–2355.
34. Kitsios GD, Thaler DE, Kent DM. Potentially large yet uncertain benefts: a metaanalysis of patent foramen ovale closure trials. Stroke. 2013;44:2640–2643.
35. Marini C, Totaro R, De Santis F, Ciancarelli I, Baldassarre M, Carolei A. Stroke in young adults in the community-based L’Aquila registry: incidence and prognosis. Stroke. 2001;32:52–56.
36. Jacobs BS, Boden-Albala B, Lin I F, Sacco RL. Stroke in the young in the Northern Manhattan Stroke Study. Stroke. 2002;33: 2789–2793.
37. Westover AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry. 2007;64:495–502.
38. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6:182–187.
39. Rutten-Jacobs LC, Arntz RM, Maaijwee NA, et al. Long-term mortality after stroke among adults aged 18 to 50 years. JAMA. 2013;309:1136–1144.
40. Ellis C. Stroke in young adults. Disabil Health J. 2010;3:222–224.
41. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25: 457–507.
42. Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the Primary Prevention of Stroke. A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:3754–3832.
43. Polívka J, Rohan V, Ševčík P, Polívka J Jr. Personalized approach to primary and secondary prevention of ischemic stroke. EPMA J. 2014;5:9.
44. Gaciong Z, Siński M, Lewandowski J. Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses. Curr Hypertens Rep. 2013;15:559–574.
45. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129 Suppl 2:S1–S45.
46. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989;298:789–794.
47. Feigin V, Parag V, Lawes CM, et al; Asia Pacifc Cohort Studies Collaboration. Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacifc region: an overview of 26 cohorts involving 306,620 participants. Stroke. 2005;36:1360–1365.
48. Feigin VL, Krishnamurthi R. Stroke prevention in the developing world. Stroke. 2011;42:3655–3658.
49. He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: metaanalysis of cohort studies. Lancet. 2006;367: 320–326.
50. Li XY, Cai XL, Bian PD, Hu LR. High salt intake and stroke: meta-analysis of the epidemiologic evidence. CNS Neurosci Ther. 2012;18:691–701.
51. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk. A meta-analysis. Stroke. 2003;34:2475–2482.
52. Putaala J, Haapaniemi E, Matseo AJ, et al. Recurent ischemic events in young adults after frst-ever ischemic stroke. Ann Neurol. 2010;68:661–671.
53. Aarnio K, Haapaniemi E, Melkas S, Kaste M, Tatlisumak T, Putaala J. Long-term mortality after frst-ever and recurrent stroke in young adults. Stroke. 2014;45:2670–2676.
54. Åsberg S, Henriksson KM, Farahmand B, et al. Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register. Stroke. 2010;41: 1338–1342.
55. Palnum KH, Mehnert F, Andersen G, et al. Use of secondary medical prophylaxis and clinical outcome among patients with ischemic stroke: a nationwide follow-up study. Stroke. 2012;43:802–807.
56. Putaala J, Haapaniemi E, Kaste M, Tatlisumak T. Statins after ischemic stroke of undetermined etiology in young adults. Neurology. 2011;77:426–430.
57. Smajlović Dž, Salihović D, Ibrahimagić OĆ, Sinanović O, Burina A. Stroke in patients with diabetes mellitus: a hospital based study. Med Arh. 2006;60(6 Suppl 2):63–65.
58. Jia Q, Zhao X, Wang C, et al. Diabetes and poor outcomes within 6 months after acute ischemic stroke: the China National Stroke Registry. Stroke. 2011;42:2758–2762.
59. Putaala J, Liebkind R, Gordin D, et al. Diabetes mellitus and isch-emic stroke in the young: clinical features and longterm prognosis. Neurolog y. 2011;76:1831–1837.
60. Furie KL, Goldstein LB, Albers G W, et al; on behalf of the American Heart Association Stroke Council, Council on Quality of Care and Outcomes Research, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation: a Science Advisory for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:3442–3453.
61. Lip G Y, Bongiorni MG, Dobreanu D, et al; Scientific Initiative Committee, European Heart Rhythm Association. Novel oral anticoagulants for stroke prevention in atrial fbrillation: results of the European Heart Rhythm Association survey. Europace. 2013;15:1526–1532.
62. Fuentes B, Gállego J, Gil-Nunez A, et al. Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type. Neurología. 2014;29:168–183.
63. O’Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC; American Heart Association. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/ American Stroke Association and the American College of Cardiology Foundation. Circulation. 2009;119:2743–2747.
64. Menon R, Kerry S, Norris J W, Markus HS. Treatment of cervical artery dissection: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2008;79:1122–1127.
65. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2011;42:227–276.
66. Bushnell CD, Olson DM, Zhao X, et al. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 2011;77:1182–1190.
67. Leistner S, Benik S, Laumeier I, et al. Secondary prevention after minor stroke and TIA – usual care and development of a support program. PLoS One. 2012;7:e49985.